113 related articles for article (PubMed ID: 28944820)
1. Identification of 14‑3‑3ζ as a potential biomarker in gastric cancer by proteomics‑based analysis.
Liu XX; Ye H; Wang P; Zhang Y; Zhang JY
Mol Med Rep; 2017 Nov; 16(5):7759-7765. PubMed ID: 28944820
[TBL] [Abstract][Full Text] [Related]
2. Proteomics-based identification of a tumor-associated antigen and its corresponding autoantibody in gastric cancer.
Tsunemi S; Nakanishi T; Fujita Y; Bouras G; Miyamoto Y; Miyamoto A; Nomura E; Takubo T; Tanigawa N
Oncol Rep; 2010 Apr; 23(4):949-56. PubMed ID: 20204278
[TBL] [Abstract][Full Text] [Related]
3. Tumor-associated autoantibody signature for the early detection of gastric cancer.
Zayakin P; Ancāns G; Siliņa K; Meistere I; Kalniņa Z; Andrejeva D; Endzeliņš E; Ivanova L; Pismennaja A; Ruskule A; Doniņa S; Wex T; Malfertheiner P; Leja M; Linē A
Int J Cancer; 2013 Jan; 132(1):137-47. PubMed ID: 22684876
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody against 14-3-3 zeta: a serological marker in detection of gastric cancer.
Qin J; Wang S; Wang P; Wang X; Ye H; Song C; Dai L; Wang K; Jiang B; Zhang J
J Cancer Res Clin Oncol; 2019 May; 145(5):1253-1262. PubMed ID: 30887154
[TBL] [Abstract][Full Text] [Related]
5. Identification of 14-3-3β in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker.
Tseng CW; Yang JC; Chen CN; Huang HC; Chuang KN; Lin CC; Lai HS; Lee PH; Chang KJ; Juan HF
Proteomics; 2011 Jun; 11(12):2423-39. PubMed ID: 21598387
[TBL] [Abstract][Full Text] [Related]
6. Emerging blood-based biomarkers for detection of gastric cancer.
Kalniņa Z; Meistere I; Kikuste I; Tolmanis I; Zayakin P; Linē A
World J Gastroenterol; 2015 Nov; 21(41):11636-53. PubMed ID: 26556992
[TBL] [Abstract][Full Text] [Related]
7. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma.
Fujita Y; Nakanishi T; Hiramatsu M; Mabuchi H; Miyamoto Y; Miyamoto A; Shimizu A; Tanigawa N
Clin Cancer Res; 2006 Nov; 12(21):6415-20. PubMed ID: 17085654
[TBL] [Abstract][Full Text] [Related]
8. Identification and evaluation of novel serum autoantibody biomarkers for early diagnosis of gastric cancer and precancerous lesion.
Zhu Q; He P; Zheng C; Chen Z; Qi S; Zhou D; Li Y; Ouyang Q; Zi H; Tang H; Xing J; Xie Y; Zhu S; Ren J; Huang J
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8369-8378. PubMed ID: 37079049
[TBL] [Abstract][Full Text] [Related]
9. Serum Protein Markers for the Early Detection of Lung Cancer: A Focus on Autoantibodies.
Broodman I; Lindemans J; van Sten J; Bischoff R; Luider T
J Proteome Res; 2017 Jan; 16(1):3-13. PubMed ID: 27769114
[TBL] [Abstract][Full Text] [Related]
10. Serum autoantibodies as biomarkers for early cancer detection.
Tan HT; Low J; Lim SG; Chung MC
FEBS J; 2009 Dec; 276(23):6880-904. PubMed ID: 19860826
[TBL] [Abstract][Full Text] [Related]
11. Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma.
Zhou SL; Ku JW; Fan ZM; Yue WB; Du F; Zhou YF; Liu YL; Li Y; Tang S; Hu YL; Hu XP; Hou ZC; Liu J; Liu Y; Feng XS; Wang LD
Dis Esophagus; 2015; 28(4):371-9. PubMed ID: 24612004
[TBL] [Abstract][Full Text] [Related]
12. Identification of tubulin beta chain, thymosin beta-4-like protein 3, and cytochrome b-c₁ complex subunit 1 as serological diagnostic biomarkers of gastric cancer.
Fan NJ; Li K; Liu QY; Wang XL; Hu L; Li JT; Gao CF
Clin Biochem; 2013 Oct; 46(15):1578-84. PubMed ID: 23747515
[TBL] [Abstract][Full Text] [Related]
13. S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis.
Wu W; Juan WC; Liang CR; Yeoh KG; So J; Chung MC
Proteomics Clin Appl; 2012 Apr; 6(3-4):152-62. PubMed ID: 22532451
[TBL] [Abstract][Full Text] [Related]
14. Anti-FIRΔexon2 autoantibody as a novel indicator for better overall survival in gastric cancer.
Kobayashi S; Hiwasa T; Ishige T; Kano M; Hoshino T; Rahmutulla B; Seimiya M; Shimada H; Nomura F; Matsubara H; Matsushita K
Cancer Sci; 2021 Feb; 112(2):847-858. PubMed ID: 33306856
[TBL] [Abstract][Full Text] [Related]
15. Proteomic-based identification of HSP70 as a tumor-associated antigen in ovarian cancer.
Liu XX; Ye H; Wang P; Li LX; Zhang Y; Zhang JY
Oncol Rep; 2017 May; 37(5):2771-2778. PubMed ID: 28339059
[TBL] [Abstract][Full Text] [Related]
16. Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma.
Fujita Y; Nakanishi T; Miyamoto Y; Hiramatsu M; Mabuchi H; Miyamoto A; Shimizu A; Takubo T; Tanigawa N
Cancer Lett; 2008 May; 263(2):280-90. PubMed ID: 18334280
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylated DNA as potential biomarkers for gastric cancer diagnosis.
Zheng Y; Chen L; Li J; Yu B; Su L; Chen X; Yu Y; Yan M; Liu B; Zhu Z
Clin Biochem; 2011 Dec; 44(17-18):1405-11. PubMed ID: 21945024
[TBL] [Abstract][Full Text] [Related]
18. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients.
Toiyama Y; Tanaka K; Kitajima T; Shimura T; Imaoka H; Mori K; Okigami M; Yasuda H; Okugawa Y; Saigusa S; Ohi M; Inoue Y; Mohri Y; Goel A; Kusunoki M
Carcinogenesis; 2015 Dec; 36(12):1474-83. PubMed ID: 26420253
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel biomarker in tangeretin‑induced cell death in AGS human gastric cancer cells.
Yumnam S; Raha S; Kim SM; Venkatarame Gowda Saralamma V; Lee HJ; Ha SE; Heo JD; Lee SJ; Kim EH; Lee WS; Kim JA; Kim GS
Oncol Rep; 2018 Dec; 40(6):3249-3260. PubMed ID: 30272339
[TBL] [Abstract][Full Text] [Related]
20. Clinical Significance of Serum p53 Antibody in the Early Detection and Poor Prognosis of Gastric Cancer.
Kunizaki M; Fukuda A; Wakata K; Tominaga T; Nonaka T; Miyazaki T; Matsumoto K; Sumida Y; Hidaka S; Yasutake T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
Anticancer Res; 2017 Apr; 37(4):1979-1984. PubMed ID: 28373470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
